Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer - Contacts and Locations

Rebeccamycin Analog and Cisplatin With or Without Filgrastim in Treating Patients With Advanced Cancer

This study has been completed.

Study NCT00004189. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00004189

Locations


United States, Texas
	Cancer Therapy and Research Center
	San Antonio, Texas, United States, 78229
	St. Luke's Lutheran Hospital
	San Antonio, Texas, United States, 78229
	University of Texas Health Science Center at San Antonio
	San Antonio, Texas, United States, 78229-3900

Sponsors and Collaborators

University of Texas

National Cancer Institute (NCI)

Investigators


Study Chair:	Lisa Hammond, MD	University of Texas